(Q52024048)

20 April 2018

title

Impaired neurotransmitter systems by Abeta amyloidosis in APPsw transgenic mice overexpressing amyloid beta protein precursor. (English)

1 reference

20 April 2018

1 reference

1 reference

Tomidokoro Y

1

1 reference

20 April 2018

Harigaya Y

2

1 reference

20 April 2018

Matsubara E

3

1 reference

20 April 2018

Ikeda M

4

1 reference

20 April 2018

Kawarabayashi T

5

1 reference

20 April 2018

Okamoto K

6

1 reference

20 April 2018

Shoji M

7

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 October 2000

1 reference

20 April 2018

published in

Neuroscience Letters

1 reference

20 April 2018

volume

292

1 reference

20 April 2018

issue

3

1 reference

20 April 2018

page(s)

155-158

1 reference

20 April 2018

Substance P immunoreactivity within neuritic plaques.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Choline acetyltransferase immunoreactivity in neuritic plaques of Alzheimer brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Evidence that transmitter-containing dystrophic neurites precede those containing paired helical filaments within senile plaques in the entorhinal cortex of nondemented elderly and Alzheimer's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Accumulation of beta-amyloid fibrils in pancreas of transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901443-9

7 January 2021

10.1016/S0304-3940(00)01443-9

Identifiers

DOI

1 reference

20 April 2018

PubMed ID

11018300

1 reference

20 April 2018